Sign Out
Pregnancy: Data on a limited number of exposed pregnancies during the first trimester are insufficient to draw a conclusion on the adverse effects of xylometazoline on pregnancy or on the health of the fetus/newborn infant. To date no other appropriate epidemiological data are available. Animal studies showed reproduction toxicity above therapeutic dosing levels. SNUP STADA should only be used in pregnancy after a careful benefit/risk assessment. Because overdosing may impair the blood supply to the unborn child, during pregnancy the recommended dosage must not be exceeded.
Lactation: It is unknown whether xylometazoline passes into human breast milk. During lactation SNUP STADA should therefore be used only after a careful benefit/risk assessment. Because overdosing might reduce the milk production, during lactation the recommended dosage must not be exceeded.
